Found 3 results
Filters: Keyword is PTEN Phosphohydrolase  [Clear All Filters]
2025
Mao N, Lee YSun, Salsabeel N, Zhang Z, Li D, Kaur H, Chen X, Chang Q, Mehta S, Barnes J et al..  2025.  Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers.. Sci Adv. 11(6):eadq3802.
2017
Patnaik A, Swanson KD, Csizmadia E, Solanki A, Landon-Brace N, Gehring MP, Helenius K, Olson BM, Pyzer AR, Wang LC et al..  2017.  Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.. Cancer Discov. 7(7):750-765.
Herting CJ, Chen Z, Pitter KL, Szulzewsky F, Kaffes I, Kaluzova M, Park JC, Cimino PJ, Brennan C, Wang B et al..  2017.  Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.. Glia. 65(12):1914-1926.